stockrowADC Therapeutics SA (ADCT) vs Lifecore Biomedical, Inc. (LFCR)
- ADC Therapeutics SA ADCT 1.66 −3.49%
- Lifecore Biomedical, Inc. LFCR 6.39 −0.78%
ADC Therapeutics SA and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $242.6M against $209.4M — 1.2× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −18.2%. Lifecore Biomedical, Inc. has the higher net margin (−65.9% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lifecore Biomedical, Inc. leads on 9 and ADC Therapeutics SA on 7.
Valuation
Profitability
| Metric | ADCT | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 88.86% | 27.38% | 53.51% |
| Operating margin | (125.08%) | (5.33%) | 0.00% |
| Net margin | (121.77%) | (65.91%) | (2.45%) |
| Free cash flow margin | (127.72%) | 9.86% | 0.00% |
| Return on equity | 45.35% | 178.69% | (0.80%) |
| Return on assets | (32.25%) | (32.36%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack